LA County recorded 2,438 total drug-related overdose deaths in 2024, with opioids — primarily fentanyl — accounting for the majority of fatalities. (Source: LA County DPH, June 2025)

Ready to Take the Next Step?

Our admissions team is available 24/7 to verify your insurance and walk you through the process. Free, confidential, no obligation.

📞 Call (213) 436-1475 Verify Your Insurance — Free

What Is Medication-Assisted Treatment (MAT)?

Medication-assisted treatment combines FDA-approved medications with behavioral therapy for opioid use disorder. Decades of clinical evidence show MAT dramatically reduces relapse rates, overdose deaths, and the medical complications of long-term opioid use. MAT is not 'replacing one addiction with another' — it is the clinical standard of care for opioid use disorder.

Buprenorphine, Methadone, and Naltrexone Explained

Buprenorphine (Suboxone, Subutex) is a partial opioid agonist that reduces cravings and withdrawal while producing a ceiling effect that limits euphoria and overdose risk. Methadone is a full opioid agonist delivered through federally regulated clinics; it is highly effective for high-dose opioid dependence. Naltrexone (Vivitrol) is a monthly injection that blocks the effects of opioids and reduces relapse risk — used after detox is complete.

MAT + Therapy: Why Both Matter

Medication addresses the neurological and physical dimensions of opioid use disorder. Therapy addresses the behavioral patterns, emotional drivers, and co-occurring mental health conditions that underlie continued use. Together, they produce the strongest long-term outcomes. MAT without therapeutic support is less effective; therapy without medication leaves patients vulnerable to relapse during physical cravings.

Who Qualifies for Opioid Treatment?

Anyone with a diagnosis of opioid use disorder — regardless of the specific opioid (heroin, fentanyl, prescription painkillers, or a mix) — is a candidate for MAT and residential opioid treatment. The clinical team at the program conducts a comprehensive assessment during intake to develop an individualized treatment plan.

Does Insurance Cover MAT in California?

Yes. Under California's SB 855 parity law, opioid use disorder treatment — including MAT — is a covered service. Most PPO plans cover buprenorphine, methadone referrals, naltrexone, and associated residential and outpatient care. Call (213) 436-1475 for a free insurance verification.

Ready to Take the Next Step?

Our admissions team is available 24/7 to verify your insurance and walk you through the process. Free, confidential, no obligation.

📞 Call (213) 436-1475 Verify Your Insurance — Free

Frequently Asked Questions

How long does someone stay on MAT?

There is no fixed answer. Some clients taper off MAT after months or years; others remain on medication long-term. The evidence supports extended MAT for most clients with moderate to severe opioid use disorder.

Ready to Take the Next Step?

Our admissions team is available 24/7 to verify your insurance and walk you through the process. Free, confidential, no obligation.

📞 Call (213) 436-1475 Verify Your Insurance — Free
Call 24/7: (213) 436-1475